<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073811429858</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073811429858</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Communication</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mitochondrial Disease in 22q13 Duplication Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Frye</surname>
<given-names>Richard E.</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-0883073811429858">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073811429858"/>
</contrib>
</contrib-group>
<aff id="aff1-0883073811429858">Department of Pediatrics, Division of Child Neurology, Arkansas Children’s Hospital, Little Rock, AR, USA</aff>
<author-notes>
<corresp id="corresp1-0883073811429858">Richard E. Frye, MD, PhD, Department of Pediatrics, Division of Child Neurology, Arkansas Children’s Hospital Research Institute, Slot 512-41B, 13 Children's Way, Little Rock, AR 72202 Email: <email>REFrye@uams.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>7</issue>
<fpage>942</fpage>
<lpage>949</lpage>
<history>
<date date-type="received">
<day>2</day>
<month>9</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>7</day>
<month>10</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>10</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Both copy number changes in the 22q13 region and mitochondrial disease have been associated with autism spectrum disorder. In this report, for the first time, a girl with autism spectrum disorder is described who exhibits both mitochondrial disease and a 22q13.1-33 duplication. This child demonstrated hypotonia, developmental delays, growth deficiency, microcephaly, dysmorphic facial features, and white matter abnormalities, consistent with previous cases of 22q13 region duplication. The patient also demonstrated a unique pattern of electron transport chain abnormalities with marked decreases in complex II and II/III in fibroblasts and complex I/III and II/III in muscle tissue. The 22q13.1-33 region contains 6 genes associated with mitochondrial function. Thus, disruption of this chromosomal region could cause many of the clinical findings in this child through disruption of mitochondrial function. Therefore, a mitochondrial workup should be considered in individuals with copy number changes within the 22q13 region, such as those with Phelan–McDermid syndrome.</p>
</abstract>
<kwd-group>
<kwd>epilepsy</kwd>
<kwd>mitochondrial disorder</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>22q13 duplication</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The autism spectrum disorders are a heterogeneous group of neurodevelopmental disorders characterized by impairments in communication and social interaction along with restrictive and repetitive behaviors.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811429858">1</xref>
</sup> Many of the cognitive and behavioral features of the autism spectrum disorders are believed to arise from central nervous system dysfunction, but non-central nervous system abnormalities have been associated with autism spectrum disorder.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811429858">2</xref>,<xref ref-type="bibr" rid="bibr3-0883073811429858">3</xref>
</sup> Recent studies have implicated dysfunction of physiological systems aside from the central nervous system in individuals with autism spectrum disorder. Indeed, dysfunction of the immune, detoxification, redox regulation/oxidative stress, and energy generation systems has been described.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811429858">2</xref>
<xref ref-type="bibr" rid="bibr3-0883073811429858"/>
<xref ref-type="bibr" rid="bibr4-0883073811429858"/>–<xref ref-type="bibr" rid="bibr5-0883073811429858">5</xref>
</sup> This suggests that the underlying abnormality, in at least some children with autism spectrum disorder, may arise from systemic, rather than central nervous system specific, dysfunction.<sup>
<xref ref-type="bibr" rid="bibr4-0883073811429858">4</xref>,<xref ref-type="bibr" rid="bibr5-0883073811429858">5</xref>
</sup> This has expanded the view of the possible etiological mechanisms causing autism spectrum disorders and can help explain the non–central nervous system abnormalities seen in some children with autism spectrum disorder.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811429858">2</xref>
<xref ref-type="bibr" rid="bibr3-0883073811429858"/>
<xref ref-type="bibr" rid="bibr4-0883073811429858"/>–<xref ref-type="bibr" rid="bibr5-0883073811429858">5</xref>
</sup>
</p>
<p>Recently, mitochondrial dysfunction has been proposed to explain the connection between the diverse medical symptoms associated with autism spectrum disorders.<sup>
<xref ref-type="bibr" rid="bibr2-0883073811429858">2</xref>
</sup> A recent meta-analysis found that, in previous studies, about 5% of children with autism spectrum disorder met criteria for mitochondrial disease, while as many as 30% of children with autism spectrum disorder manifested biomarkers of mitochondrial dysfunction.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811429858">3</xref>
</sup> This meta-analysis found that only 23% of the children diagnosed with autism spectrum disorder and mitochondrial disease have a known abnormality in mitochondria deoxyribonucleic acid.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811429858">3</xref>
</sup> Although abnormalities in nuclear genes can also cause mitochondrial dysfunction, nuclear genes abnormalities have been rarely reported in children with autism spectrum disorder and mitochondrial disease.<sup>
<xref ref-type="bibr" rid="bibr3-0883073811429858">3</xref>
</sup> In fact, in a review of 112 published cases of children diagnosed with both mitochondrial disease and autism spectrum disorder, only 1 case implicated a nuclear gene, the <italic>SCO2</italic> gene,<sup>
<xref ref-type="bibr" rid="bibr6-0883073811429858">6</xref>
</sup> a gene which controls cytochrome c oxidase assembly.<sup>
<xref ref-type="bibr" rid="bibr7-0883073811429858">7</xref>
</sup> Mutations in <italic>SCO2</italic> have been otherwise linked to fatal infantile cardioencephalomyopathy<sup>
<xref ref-type="bibr" rid="bibr7-0883073811429858">7</xref>
<xref ref-type="bibr" rid="bibr8-0883073811429858"/>
<xref ref-type="bibr" rid="bibr9-0883073811429858"/>–<xref ref-type="bibr" rid="bibr10-0883073811429858">10</xref>
</sup> and spontaneous abortion.<sup>
<xref ref-type="bibr" rid="bibr9-0883073811429858">9</xref>
</sup>
</p>
<p>In the current report, we present a case of a child with autism spectrum disorder and mitochondrial disease who manifests duplication in 22q13.1-22q13.33, a chromosomal region that includes the <italic>SCO2</italic> gene. Only 1 other chromosomal duplication has been linked to mitochondrial disease and autism spectrum disorder, an inverted duplication in 15q11-13 in 2 children.<sup>
<xref ref-type="bibr" rid="bibr11-0883073811429858">11</xref>
</sup> This report adds to the understanding of the connection between autism spectrum disorder and mitochondrial disease and helps broaden the understanding of the pathophysiology associated with chromosomal duplications.</p>
<sec id="section1-0883073811429858">
<title>Case Report</title>
<p>The patient was born to a 27-year-old G2P1-2 woman through a gestation complicated by oligohydramnios and diet-controlled gestational diabetes. She was born preterm at 34 weeks’ gestation with an unremarkable neonatal course. Development was normal until 5 months old when cyanotic episodes, later diagnosed as Sandifer syndrome, began. Development was globally delayed—she did not crawl until 21 months, she did not walk until 30 months, and she did not say “Mama” until 3 years of age. At 3 years of age, she was diagnosed with autism spectrum disorder. She had a past medical history of hip dysplasia, eczema, and a tonsillectomy and adenoidectomy.</p>
<p>At 4 years of age, the patient suffered from a 10-minute generalized tonic–clonic seizure. She was referred to our clinic for further evaluation. The Denver Developmental Scale II demonstrated social milestones at 2 years of age, fine motor milestones at 15 months of age, language milestones at 1 year of age, and gross motor milestones at 3 years of age. Family history was significant for early dementia and bipolar disorder on the parental side of the family and multiple miscarriages in the mother and the maternal grandmother. Four siblings had no neurodevelopmental problems.</p>
<p>Physical examination demonstrated symmetric growth retardation. Head circumference was 46 cm (&lt;1%ile), weight was 13 kg (&lt;1%), and height was 91.5 cm (&lt;1%). Skin examination demonstrated a maculopapular rash on the back and fine capillary hemangiomas on her cheeks. Dysmorphology included small forehead, low-set small ears, small eyes, and midface hypoplasia.</p>
<p>The patient was nonverbal but unusually friendly. She spontaneously approached the examiner, made eye contact, and tried to pull the examiner out the door with her. She had frequent repetitive movements—she repetitively ran into the center of the examining room and rocked back and forth. The patient met criteria for the diagnosis of autistic disorder per <italic>Diagnostic and Statistical Manual of Mental Disorders</italic>, fourth edition, criteria.<sup>
<xref ref-type="bibr" rid="bibr1-0883073811429858">1</xref>
</sup> The autism diagnostic observation schedule examination further confirmed the diagnosis of autistic disorder.<sup>
<xref ref-type="bibr" rid="bibr12-0883073811429858">12</xref>
</sup>
</p>
<p>A 23-hour electroencephalogram demonstrated frequent moderate-to-high-amplitude focal sharp waves, spikes, and spike-and-wave discharges arising from the right centrotemporal region, at times independently, but usually synchronously with additional spikes and spike-and-wave discharges arising from the left centrotemporal region. Discharges were more frequent on the right compared with the left. Discharges were most prominent during drowsiness and sleep when they occurred in semirhythmic runs at 1 to 2 Hz. Intermittent focal right posterior temporal and posterior quadrant slowing in the delta and theta range was also seen. There were occasional runs of bifrontal beta and delta activity.</p>
<p>Metabolic workup demonstrated an elevation in lactate (3.9 [0.5–2.2] mg/dL); pyruvate (0.166 [0.030–0.107] mmol/L); creatine kinase (202 U/L [30–200]); serum alanine-to-lysine ratio (2.6 [&lt;2.5]); short-, medium-, and long-chain acyl-carnitines (C6 0.43 [≤0.12] μmol/L, C8 0.4 [≤0.23] μmol/L, C10 0.88 [≤0.35] μmol/L, C10:1 0.48 [≤0.41] μmol/L, C12 0.19 [≤0.12] μmol/L, C14 0.15 [≤0.07] μmol/L, C14:1 0.58 [≤0.23] μmol/L, C14:2 0.13 [≤0.12] μmol/L, C16 0.36 [≤0.10] μmol/L, C16:1 0.08 [≤0.05] μmol/L, C18 0.10 [≤0.05] μmol/L, C18:1 0.56 [≤0.16] μmol/L, C18:2 0.13 [≤0.08] μmol/L); and urine organic acids (succinic 57.7 [≤51] mmol/mol creatinine, fumaric 4.5 [≤2.2] mmol/mol creatinine, and malic 4.7 [≤2.5] mmol/mol creatinine).</p>
<p>In light of the significant abnormal laboratory values, muscle and skin biopsies were performed. Light microscopy demonstrated mild myofiber size irregularity, fibers with increased sarcoplasmic lipid and succinate dehydrogenase–hyperreactive (“ragged-blue”) fibers (see <xref ref-type="fig" rid="fig1-0883073811429858">Figure 1A</xref>, <xref ref-type="fig" rid="fig1-0883073811429858">B</xref>). Electron microscopy demonstrated rare subsarcolemmal myelin figures, an increased number of subsarcolemmal mitochondria with mild irregularities of cristae, mitochondria undergoing degeneration and showing increased lipid-like deposits (see <xref ref-type="fig" rid="fig1-0883073811429858">Figure 1C</xref>, <xref ref-type="fig" rid="fig1-0883073811429858">D</xref>).</p>
<fig id="fig1-0883073811429858" position="float">
<label>Figure 1.</label>
<caption>
<p>Muscle biopsy from patient with 22q13 duplication. (A) Oil red “O” stain demonstrated an increase sarcoplasmic lipid. (B) Scattered succinate dehydrogenase–hyperreactive “ragged blue” fibers. (C) Electron microscopy demonstrated increased subsarcolemmal mitochondria. (D) Electron microscopy demonstrates increased lipid-like deposits</p>
</caption>
<graphic xlink:href="10.1177_0883073811429858-fig1.tif"/>
</fig>
<p>Functional electron transport chain studies were conducted on the muscle tissue and fibroblasts derived from the skin (Baylor Medical Genetics Laboratory, Houston, Texas).<sup>
<xref ref-type="bibr" rid="bibr13-0883073811429858">13</xref>
</sup> Electron transport chain results demonstrated different patterns in muscle tissue and fibroblasts. Uncorrected electron transport chain function in muscle tissue was depressed in all complexes except complex II with an elevation in citrate synthase indicating mitochondrial proliferation consistent with the electron microscopy findings (<xref ref-type="fig" rid="fig2-0883073811429858">Figure 2A</xref>). In comparison, electron transport chain function in fibroblasts was overactive except for complex II and II/III with no change in citrate synthase, suggesting no compensatory mitochondrial proliferation (<xref ref-type="fig" rid="fig2-0883073811429858">Figure 2D</xref>). Correcting for citrate synthase demonstrated a marked depression in complex function, especially in complex I/III and II/III of the muscle tissue (<xref ref-type="fig" rid="fig2-0883073811429858">Figure 2B</xref>). Because of the conspicuous elevation in complex function in fibroblasts, electron transport chain function was normalized with respect to the complex with the maximum function (<xref ref-type="fig" rid="fig2-0883073811429858">Figure 2C</xref>, <xref ref-type="fig" rid="fig2-0883073811429858">F</xref>) since some case reports of mitochondrial dysfunction consider relative electron transport chain function when conspicuous increases in complex function are found.<sup>
<xref ref-type="bibr" rid="bibr14-0883073811429858">14</xref>,<xref ref-type="bibr" rid="bibr15-0883073811429858">15</xref>
</sup> With correction to the maximum activity, complex I/III and II/III function were found to be markedly decreased (&lt;50% normalized activity) in muscle tissue and complex II and complex II/III were found to be markedly decreased in fibroblasts (<xref ref-type="fig" rid="fig2-0883073811429858">Figure 2C</xref>, <xref ref-type="fig" rid="fig2-0883073811429858">F</xref>). Fibroblasts derived from skin were incubated with D3-palmitate and <sc>l</sc>-carnitine in duplicate for 72 hours (Baylor Institute of Metabolic Disease, Dallas, Texas)<sup>
<xref ref-type="bibr" rid="bibr16-0883073811429858">16</xref>
</sup> and demonstrated marked elevations in D3-C4, suggesting a short-chain fatty acid or an electron transport chain disorder (<xref ref-type="fig" rid="fig2-0883073811429858">Figure 2G</xref>).</p>
<fig id="fig2-0883073811429858" position="float">
<label>Figure 2.</label>
<caption>
<p>Functional electron transport chain (ETC) studies for muscle tissue and fibroblasts. (A, D) Uncorrected electron transport chain function in muscle tissue and fibroblasts. In the muscle tissue, all complexes except complex II were depressed and citrate synthase was elevated. In fibroblasts, all complexes demonstrated overactivity except for complex II and II/III with no change in citrate synthase. (B, E) Electron transport chain function corrected for citrate synthase. In muscle tissue, electron transport chain complex function was considerably depressed. (C, F) Electron transport chain function normalized with respect to the complex with maximum activity. In muscle tissue, complex I/III and II/III were markedly depressed in function, while complex II and complex II/III were markedly depressed in fibroblasts. (G) Beta-oxidation studies of fibroblasts demonstrated marked elevations in short-chain fatty acids.</p>
</caption>
<graphic xlink:href="10.1177_0883073811429858-fig2.tif"/>
</fig>
<p>Magnetic resonance imaging of the brain demonstrated nonspecific bilateral small focal areas of increased T2 and fluid attenuated inverse recovery signal in the occipital lobes most consistent with incomplete myelination (<xref ref-type="fig" rid="fig3-0883073811429858">Figure 3A</xref>, <xref ref-type="fig" rid="fig3-0883073811429858">B</xref>) and mild prominence of the right occipital and temporal horns (<xref ref-type="fig" rid="fig3-0883073811429858">Figure 3C</xref>, <xref ref-type="fig" rid="fig3-0883073811429858">D</xref>). Single voxel magnetic resonance spectroscopy of the bilateral deep gray matter and white matter was normal.</p>
<fig id="fig3-0883073811429858" position="float">
<label>Figure 3.</label>
<caption>
<p>Magnetic resonance fluid-attenuated inverse recovery images of the brain. (A, B) Subtle nonspecific small focal areas of increased signal were seen in the occipital lobes bilaterally, most consistent with incomplete myelination. (C, D) Mild prominence of the right occipital and temporal horns was also seen.</p>
</caption>
<graphic xlink:href="10.1177_0883073811429858-fig3.tif"/>
</fig>
<p>GeneDx high-resolution oligonucleotide array (GeneDX v4, Gaithersburg, Maryland) demonstrated a 10.6-Mb duplication from 22q13.1-22q13.33 (40,561,491-51,186,190) that did not involve the minimum critical region for 22q13.3 deletion syndrome (SHANK3, ACR, and RABL2B genes) also known as Phelan–McDermid syndrome. Quantitative confirmation of the duplication was performed by polymerase chain reaction analysis of the FBLN1 gene in 22q13.31. Short-chain acyl-CoA dehydrogenase sequencing of exons 1-10 was found to be normal (GeneDx).<sup>
<xref ref-type="bibr" rid="bibr17-0883073811429858">17</xref>
</sup> An oligonucleotide array comparative genomic hybridization analysis demonstrated no deletions or duplications in approximately 180 nuclear genes involved in mitochondrial function, including genes involved in fatty-acid oxidation, carnitine metabolism, mitochondrial deoxyribonucleic acid biogenesis, maintenance, transcription and translation, or electron transport chain complex assembly (MitoMet, Baylor Medical Genetics Laboratory) aside from the genes involved in the duplicated chromosomal region. Mitochondrial deoxyribonucleic acid sequencing, performed using standard laboratory methodology, was unremarkable (Baylor Medical Genetics Laboratory).<sup>
<xref ref-type="bibr" rid="bibr18-0883073811429858">18</xref>
<xref ref-type="bibr" rid="bibr19-0883073811429858"/>–<xref ref-type="bibr" rid="bibr20-0883073811429858">20</xref>
</sup> Mitochondrial deoxyribonucleic acid content of the muscle was found to be elevated at 161% of normal.<sup>
<xref ref-type="bibr" rid="bibr21-0883073811429858">21</xref>,<xref ref-type="bibr" rid="bibr22-0883073811429858">22</xref>
</sup>
</p>
<p>A lumbar puncture demonstrated normal cerebrospinal fluid glucose (58 [45-80] mg/dL), protein (40 [15-45] mg/dL), red blood cell count (0 [0] cells/μL), and white cell count (0 [0-5] cells/μL). Cerebrospinal fluid pyruvate was normal (0.157 [0.06-0.190] mmol/L), but lactate was elevated (2.5 [0.6-2.2] mmol/L). Levels of neurotransmitter metabolites (homovanillic acid 622 [218-852] nmol/L, 5-hydroxy-indolacetic acid 285 [66-338] nmol/L, 3-<italic>O</italic>-methyldopa 39 [&lt;100] nmol/L), neopterin (15 [7-20] nmol/L), tetrahydrobiopterin (33 [9-40] nmol/L) and 5-methyltetrahydrofolate (69 [40-128] nmol/L) were normal. Additional blood testing performed during the lumbar puncture confirmed elevated levels of lactic acid (5.0 [0.5-2.2] mmol/L) and pyruvate (0.182 [0.030-0.107] mmol/L) and high alanine-to-lysine ratio (3.8 [&lt;2.5]). Serum neopterin was also found to be elevated (12.9 [2-10] nmol/L).</p>
</sec>
<sec id="section2-0883073811429858">
<title>Discussion</title>
<p>This report describes a girl with nonregressive autism spectrum disorder with both a 10.6-Mb duplication from 22q13.1 to 22q13.33 and a mitochondrial disease. Specifically, using the Morava et al criterion,<sup>
<xref ref-type="bibr" rid="bibr2-0883073811429858">2</xref>,<xref ref-type="bibr" rid="bibr23-0883073811429858">23</xref>
</sup> this patient demonstrated the maximum of 4 points in the clinical signs and symptoms portion of the criteria—developmental delay (1), seizures (1), gastrointestinal tract abnormalities (1), and growth abnormalities (1); the maximum of 4 points for the metabolic-imaging portion of the criteria—lactate (2), urinary tricarbon acid excretion (2), elevated cerebrospinal fluid lactate (2); and the maximum of 4 points for the muscle morphology portion of the criteria—abnormal mitochondria on electron microscopy (2) and ragged blue fibers (4). This patient’s findings provide a maximum total score for this criterion (12), which is consistent with a definite mitochondrial disease. Other findings that support a mitochondrial disease are elevations in pyruvate and acyl-carnitines, evidence of mitochondrial proliferation in the muscle, and the functional electron transport chain and beta-oxidation abnormalities.</p>
<p>No additional genetic defects were found in this patient to account for the mitochondrial disease aside from the 10.6-Mb chromosomal duplication. However, this duplicated chromosomal region contains several genes involved in mitochondrial function. The <italic>SCO2</italic> gene controls cytochrome c oxidase assembly,<sup>
<xref ref-type="bibr" rid="bibr7-0883073811429858">7</xref>
</sup> and mutations in this gene have been linked to fatal infantile cardioencephalomyopathy<sup>
<xref ref-type="bibr" rid="bibr7-0883073811429858">7</xref>
<xref ref-type="bibr" rid="bibr8-0883073811429858"/>
<xref ref-type="bibr" rid="bibr9-0883073811429858"/>–<xref ref-type="bibr" rid="bibr10-0883073811429858">10</xref>
</sup> and spontaneous abortion.<sup>
<xref ref-type="bibr" rid="bibr9-0883073811429858">9</xref>
</sup> The <italic>TYMP</italic> gene codes for a thymidine phosphorylase that balances deoxynucleotide pools,<sup>
<xref ref-type="bibr" rid="bibr24-0883073811429858">24</xref>
</sup> and mutations in this gene cause mitochondrial deoxyribonucleic acid depletion syndrome–1, an autosomal recessive progressive multisystem disorder with onset between the second and fifth decades.<sup>
<xref ref-type="bibr" rid="bibr25-0883073811429858">25</xref>
</sup> The CPT1B gene codes for muscle mitochondrial carnitine palmitoyltransferase, a protein that transports long-chain fatty acyl-CoA from the cytoplasm into the mitochondria for beta-oxidation.<sup>
<xref ref-type="bibr" rid="bibr26-0883073811429858">26</xref>
</sup> Human disease has not been associated with the <italic>CPT1B</italic> gene, but homozygous deletions in mice have caused embryonic death, and heterozygous deletions in mice have caused increased fatality after cold-challenge.<sup>
<xref ref-type="bibr" rid="bibr27-0883073811429858">27</xref>
</sup> The <italic>TRMU</italic> gene codes for a transfer ribonucleic acid 5-methlaminomethyl-2-thiouridylate methyltransferase that is essential for mitochondrial transfer ribonucleic acid modification.<sup>
<xref ref-type="bibr" rid="bibr28-0883073811429858">28</xref>
</sup> The <italic>TRMU</italic> gene has been associated with aminoglycoside-induced and nonsyndromic deafness<sup>
<xref ref-type="bibr" rid="bibr29-0883073811429858">29</xref>
</sup> and acute infantile liver failure.<sup>
<xref ref-type="bibr" rid="bibr30-0883073811429858">30</xref>
</sup> The <italic>NDUFA6</italic> gene codes for the nicotinamide adenine dinucleotide-ubiquinone oxidoreductase 1α subcomplex 6, one of the accessory subunits of electron transport chain complex I.<sup>
<xref ref-type="bibr" rid="bibr31-0883073811429858">31</xref>
</sup> The <italic>ACO2</italic> gene codes for mitochondrial aconitase, the second enzymes in the tricaboxylic acid cycle. Clearly, this chromosomal region has a concentration of mitochondrial nuclear genes, and abnormalities in this area (mutations and copy number variations) have the potential to cause mitochondrial disease.</p>
<p>Duplication in the 22q13 region has been reported in several cases with variations in the characteristics observed. Several cases have reported hypotonia,<sup>
<xref ref-type="bibr" rid="bibr32-0883073811429858">32</xref>
</sup> developmental delay,<sup>
<xref ref-type="bibr" rid="bibr32-0883073811429858">32</xref>
</sup> mental retardation,<sup>
<xref ref-type="bibr" rid="bibr33-0883073811429858">33</xref>,<xref ref-type="bibr" rid="bibr34-0883073811429858">34</xref>
</sup> autism spectrum disorder,<sup>
<xref ref-type="bibr" rid="bibr34-0883073811429858">34</xref>
</sup> bipolar disorder,<sup>
<xref ref-type="bibr" rid="bibr33-0883073811429858">33</xref>
</sup> growth deficiency,<sup>
<xref ref-type="bibr" rid="bibr32-0883073811429858">32</xref>,<xref ref-type="bibr" rid="bibr35-0883073811429858">35</xref>
</sup> retinitis pigmentosa,<sup>
<xref ref-type="bibr" rid="bibr36-0883073811429858">36</xref>
</sup> microcephaly,<sup>
<xref ref-type="bibr" rid="bibr34-0883073811429858">34</xref>,<xref ref-type="bibr" rid="bibr35-0883073811429858">35</xref>
</sup> dysmorphic facial features,<sup>
<xref ref-type="bibr" rid="bibr33-0883073811429858">33</xref>
<xref ref-type="bibr" rid="bibr34-0883073811429858"/>–<xref ref-type="bibr" rid="bibr35-0883073811429858">35</xref>
</sup> bilateral cleft lip and palate,<sup>
<xref ref-type="bibr" rid="bibr35-0883073811429858">35</xref>
</sup> cryptorchidism with hypospadias,<sup>
<xref ref-type="bibr" rid="bibr35-0883073811429858">35</xref>
</sup> hemivertebrae,<sup>
<xref ref-type="bibr" rid="bibr35-0883073811429858">35</xref>
</sup> syndactyly,<sup>
<xref ref-type="bibr" rid="bibr33-0883073811429858">33</xref>
</sup> complex heart defects,<sup>
<xref ref-type="bibr" rid="bibr35-0883073811429858">35</xref>
</sup> and white matter and hippocampus abnormalities.<sup>
<xref ref-type="bibr" rid="bibr33-0883073811429858">33</xref>
</sup> The patient described in this report demonstrated hypotonia, developmental delays, growth deficiency, microcephaly, autism spectrum disorder, dysmorphic facial features, and white matter abnormalities, like previously reported cases with duplications in this region. Of the features that the patient described in this report demonstrated, many of them, including hypotonia, developmental delays, growth deficiency, microcephaly, and white matter abnormalities, can be explained by mitochondrial disease. In addition, of the features reported in the previous 22q13 duplication cases, retinitis pigmentosa could be related to mitochondrial abnormalities,<sup>
<xref ref-type="bibr" rid="bibr37-0883073811429858">37</xref>
</sup> and bipolar disorder has also been associated with mitochondrial dysfunction.<sup>
<xref ref-type="bibr" rid="bibr38-0883073811429858">38</xref>
</sup>
</p>
<p>The identification of 2 pairs of recurrent proximal breakpoints on 22q13 suggests that this region may be prone to recombination.<sup>
<xref ref-type="bibr" rid="bibr36-0883073811429858">36</xref>
</sup> This is echoed by the fact that both 22q13 microduplication<sup>
<xref ref-type="bibr" rid="bibr32-0883073811429858">32</xref>
</sup> and 22q13 deletion syndromes<sup>
<xref ref-type="bibr" rid="bibr36-0883073811429858">36</xref>,<xref ref-type="bibr" rid="bibr39-0883073811429858">39</xref>
</sup> are recognized disorders. Unfortunately, previous case reports and case series have not investigated mitochondrial abnormalities as part of the workup for the etiology for the clinical findings in cases with copy number changes in the 22q13 region. For example, although clinical manifestation of Phelan–McDermid syndrome are believed to be due to a deletion of the <italic>SHANK3</italic> gene, chromosomal deletions in individuals with this syndrome not uncommonly include flanking regions of the <italic>SHANK3</italic> gene within the 22q13 region.<sup>
<xref ref-type="bibr" rid="bibr40-0883073811429858">40</xref>
</sup> Given that the 22q13 region has a particularly high concentration of mitochondrial genes, investigation (or at least screening) of mitochondrial disease in individuals with genetic disturbances within this region may help better define the pathologic mechanisms of clinical findings that are attributable to abnormalities in the 22q13 region and help improve the understanding of the connection between mitochondrial disease and neurodevelopmental disorders.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="other" id="fn1-0883073811429858">
<label>Author's Note</label>
<p>This study has not been presented or published previously.</p>
</fn>
<fn fn-type="conflict" id="fn2-0883073811429858">
<label>Declaration of Conflicting Interests</label>
<p>The author declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: In the past, Dr Frye has provided expert opinion for child neurology cases for both the plaintiff and defendant, including cases with children suffering from mitochondrial disorders. All proceeds from such work were provided to the Department of Pediatrics at the University of Texas, with some of these funds supporting Dr Frye’s research.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0883073811429858">
<label>Financial Disclosure/Funding</label>
<p>The author disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded in part by K23NS046565 and the Jane Botsford Johnson Foundation.</p>
</fn>
<fn fn-type="other" id="fn4-0883073811429858">
<label>Ethical Approval</label>
<p>This study was performed under an IRB approved protocol.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073811429858">
<label>1</label>
<citation citation-type="book">
<collab collab-type="author">APA</collab>. <source>Diagnostic and Statistical Manual of Mental Disorders</source>. <edition>4th ed</edition>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>; <year>1994</year>.</citation>
</ref>
<ref id="bibr2-0883073811429858">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Rossignol</surname>
<given-names>DA</given-names>
</name>
</person-group>. <article-title>Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders</article-title>. <source>Pediatr Res</source>. <year>2011</year>;<volume>69</volume>
<issue>(5 pt 2)</issue>:<fpage>41R</fpage>–<lpage>47R</lpage>.</citation>
</ref>
<ref id="bibr3-0883073811429858">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossignol</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
</person-group>. <article-title>Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis [published online ahead of print March 25, 2001]</article-title>. <source>Mol Psychiatry</source>. <comment>doi: 10.1038/mp.2010.136</comment>.</citation>
</ref>
<ref id="bibr4-0883073811429858">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname>
<given-names>MR</given-names>
</name>
</person-group>. <article-title>Contributions of the environment and environmentally vulnerable physiology to autism spectrum disorders</article-title>. <source>Curr Opin Neurol</source>. <year>2010</year>;<volume>23</volume>:<fpage>103</fpage>–<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr5-0883073811429858">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbert</surname>
<given-names>MR</given-names>
</name>
</person-group>. <article-title>Autism: a brain disorder or a disorder that affects the brain</article-title>. <source>Clin Neuropsychiatry</source>. <year>2005</year>;<volume>2</volume>:<fpage>354</fpage>–<lpage>379</lpage>.</citation>
</ref>
<ref id="bibr6-0883073811429858">
<label>6</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Scaglia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Fouladi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schmitt</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>L-J</given-names>
</name>
</person-group>. <article-title>Prevalence of autism spectrum disorders in subjects with definite diagnosis of mitochondrial cytopathies</article-title>. In: <source>American Society of Human Genetics 59th Annual Meeting</source>. <publisher-name>Honolulu, Hawaii</publisher-name>; <year>2009</year>.</citation>
</ref>
<ref id="bibr7-0883073811429858">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papadopoulou</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Sue</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>MM</given-names>
</name>
<etal/>
</person-group>. <article-title>Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in <italic>SCO2</italic>, a COX assembly gene</article-title>. <source>Nat Genet</source>. <year>1999</year>;<volume>23</volume>:<fpage>333</fpage>–<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr8-0883073811429858">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaksch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ogilvie</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutations in <italic>SCO2</italic> are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency</article-title>. <source>Hum Mol Genet</source>. <year>2000</year>;<volume>9</volume>:<fpage>795</fpage>–<lpage>801</lpage>.</citation>
</ref>
<ref id="bibr9-0883073811429858">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tay</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Shanske</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>DiMauro</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Association of mutations in <italic>SCO2</italic>, a cytochrome c oxidase assembly gene, with early fetal lethality</article-title>. <source>Arch Neurol</source>. <year>2004</year>;<volume>61</volume>:<fpage>950</fpage>–<lpage>952</lpage>.</citation>
</ref>
<ref id="bibr10-0883073811429858">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verdijk</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>de Krijger</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schoonderwoerd</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Phenotypic consequences of a novel <italic>SCO2</italic> gene mutation</article-title>. <source>Am J Med Genet</source>. <year>2008</year>;<volume>146A</volume>:<fpage>2822</fpage>–<lpage>2827</lpage>.</citation>
</ref>
<ref id="bibr11-0883073811429858">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filipek</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Juranek</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial dysfunction in autistic patients with 15q inverted duplication</article-title>. <source>Ann Neurol</source>. <year>2003</year>;<volume>53</volume>:<fpage>801</fpage>–<lpage>804</lpage>.</citation>
</ref>
<ref id="bibr12-0883073811429858">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Risi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lambrecht</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism</article-title>. <source>J Autism Dev Disord</source>. <year>2000</year>;<volume>30</volume>:<fpage>205</fpage>–<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr13-0883073811429858">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirby</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Thorburn</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Turnbull</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>RW</given-names>
</name>
</person-group>. <article-title>Biochemical assays of respiratory chain complex activity</article-title>. <source>Methods Cell Biol</source>. <year>2007</year>;<volume>80</volume>:<fpage>93</fpage>–<lpage>119</lpage>.</citation>
</ref>
<ref id="bibr14-0883073811429858">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Condie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wainwright</surname>
<given-names>MS</given-names>
</name>
</person-group>. <article-title>Acquired microcephaly, regression of milestones, mitochondrial dysfunction, and episodic rigidity in a 46, XY male with a de novo <italic>MECP2</italic> gene mutation</article-title>. <source>J Child Neurol</source>. <year>2010</year>;<volume>25</volume>:<fpage>633</fpage>–<lpage>636</lpage>.</citation>
</ref>
<ref id="bibr15-0883073811429858">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
</person-group>. <article-title>Autistic disorder with complex IV overactivity: a new mitochondrial syndrome</article-title>. <source>J Pediatr Neurol</source>. <comment>In press</comment>.</citation>
</ref>
<ref id="bibr16-0883073811429858">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roe</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Roe</surname>
<given-names>DS</given-names>
</name>
</person-group>. <article-title>Recent developments in the investigation of inherited metabolic disorders using cultured human cells</article-title>. <source>Mol Genet Metab</source>. <year>1999</year>;<volume>68</volume>:<fpage>243</fpage>–<lpage>257</lpage>.</citation>
</ref>
<ref id="bibr17-0883073811429858">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corydon</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Vockley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rinaldo</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Role of common gene variations in the molecular pathogenesis of short-chain acyl-CoA dehydrogenase deficiency</article-title>. <source>Pediatr Res</source>. <year>2001</year>;<volume>49</volume>:<fpage>18</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr18-0883073811429858">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>LJ</given-names>
</name>
</person-group>. <article-title>Molecular genetics of mitochondrial disorders</article-title>. <source>Dev Disabil Res Rev</source>. <year>2010</year>;<volume>16</volume>:<fpage>154</fpage>–<lpage>162</lpage>.</citation>
</ref>
<ref id="bibr19-0883073811429858">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>LJ</given-names>
</name>
</person-group>. <article-title>Pathogenic mitochondrial DNA mutations in protein-coding genes</article-title>. <source>Muscle Nerve</source>. <year>2007</year>;<volume>36</volume>:<fpage>279</fpage>–<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr20-0883073811429858">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Cobb</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>TJ</given-names>
</name>
</person-group>. <article-title>Molecular analysis of mitochondrial DNA point mutations by polymerase chain reaction</article-title>. <source>Methods Mol Biol</source>. <year>2006</year>;<volume>336</volume>:<fpage>135</fpage>–<lpage>143</lpage>.</citation>
</ref>
<ref id="bibr21-0883073811429858">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Perng</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>LJ</given-names>
</name>
</person-group>. <article-title>Quantitative PCR analysis of mitochondrial DNA content in patients with mitochondrial disease</article-title>. <source>Ann N Y Acad Sci</source>. <year>2004</year>;<volume>1011</volume>:<fpage>304</fpage>–<lpage>309</lpage>.</citation>
</ref>
<ref id="bibr22-0883073811429858">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>LJ</given-names>
</name>
</person-group>. <article-title>Simultaneous detection and quantification of mitochondrial DNA deletion(s), depletion, and over-replication in patients with mitochondrial disease</article-title>. <source>J Mol Diagn</source>. <year>2005</year>;<volume>7</volume>:<fpage>613</fpage>–<lpage>622</lpage>.</citation>
</ref>
<ref id="bibr23-0883073811429858">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morava</surname>
<given-names>E</given-names>
</name>
<name>
<surname>van den Heuvel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hol</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial disease criteria: diagnostic applications in children</article-title>. <source>Neurology</source>. <year>2006</year>;<volume>67</volume>:<fpage>1823</fpage>–<lpage>1826</lpage>.</citation>
</ref>
<ref id="bibr24-0883073811429858">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Akman</surname>
<given-names>HO</given-names>
</name>
<name>
<surname>Garcia-Cazorla</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice</article-title>. Hum Mol Genet <year>2009</year>;<volume>18</volume>:<fpage>714</fpage>–<lpage>722</lpage>.</citation>
</ref>
<ref id="bibr25-0883073811429858">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taanman</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Daras</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)</article-title>. <source>Neuromuscul Disord</source>. <year>2009</year>;<volume>19</volume>:<fpage>151</fpage>–<lpage>154</lpage>.</citation>
</ref>
<ref id="bibr26-0883073811429858">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamazaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Shinohara</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Shima</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Terada</surname>
<given-names>H</given-names>
</name>
</person-group>. <article-title>Isolation and characterization of cDNA and genomic clones encoding human muscle type carnitine palmitoyltransferase I</article-title>. <source>Biochim Biophys Acta</source>. <year>1996</year>;<volume>1307</volume>:<fpage>157</fpage>–<lpage>161</lpage>.</citation>
</ref>
<ref id="bibr27-0883073811429858">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>S</given-names>
</name>
<name>
<surname>You</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kerner</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Homozygous carnitine palmitoyltransferase 1b (muscle isoform) deficiency is lethal in the mouse</article-title>. <source>Mol Genet Metab</source>. <year>2008</year>;<volume>93</volume>:<fpage>314</fpage>–<lpage>322</lpage>.</citation>
</ref>
<ref id="bibr28-0883073811429858">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>MX</given-names>
</name>
</person-group>. <article-title>Identification and characterization of mouse TRMU gene encoding the mitochondrial 5-methylaminomethyl-2-thiouridylate-methyltransferase</article-title>. <source>Biochim Biophys</source>. <year>2004</year>;<volume>1676</volume>:<fpage>119</fpage>–<lpage>126</lpage>.</citation>
</ref>
<ref id="bibr29-0883073811429858">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prezant</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Agapian</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Bohlman</surname>
<given-names>MC</given-names>
</name>
<etal/>
</person-group>. <article-title>Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness</article-title>. <source>Nat Genet</source>. <year>1993</year>;<volume>4</volume>:<fpage>289</fpage>–<lpage>294</lpage>.</citation>
</ref>
<ref id="bibr30-0883073811429858">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeharia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shaag</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pappo</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Acute infantile liver failure due to mutations in the <italic>TRMU</italic> gene</article-title>. <source>Am J Hum Genet</source>. <year>2009</year>;<volume>85</volume>:<fpage>401</fpage>–<lpage>407</lpage>.</citation>
</ref>
<ref id="bibr31-0883073811429858">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Dempsey</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Liew</surname>
<given-names>CC</given-names>
</name>
</person-group>. <article-title>Identification and primary structure of five human NADH-ubiquinone oxidoreductase subunits</article-title>. <source>Biochem Biophys Res Commun</source>. <year>1997</year>;<volume>241</volume>:<fpage>589</fpage>–<lpage>594</lpage>.</citation>
</ref>
<ref id="bibr32-0883073811429858">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kubota</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>22q13 Microduplication in two patients with common clinical manifestations: a recognizable syndrome?</article-title> <source>Am J Med Genet</source>. <year>2007</year>;<volume>143A</volume>:<fpage>2804</fpage>–<lpage>2809</lpage>.</citation>
</ref>
<ref id="bibr33-0883073811429858">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pramparo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>de Gregori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>A 7 Mb duplication at 22q13 in a girl with bipolar disorder and hippocampal malformation</article-title>. <source>Am J Med Genet</source>. <year>2008</year>;<volume>146A</volume>:<fpage>1754</fpage>–<lpage>1760</lpage>.</citation>
</ref>
<ref id="bibr34-0883073811429858">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peeters</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vermeesch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names>JP</given-names>
</name>
</person-group>. <article-title>A cryptic duplication 22q13.31 to qter leads to a distinct phenotype with mental retardation, microcephaly and mild facial dysmorphism</article-title>. <source>Genet Couns</source>. <year>2008</year>;<volume>19</volume>:<fpage>365</fpage>–<lpage>371</lpage>.</citation>
</ref>
<ref id="bibr35-0883073811429858">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>JW</given-names>
</name>
</person-group>. <article-title>Trisomy chromosome (22)(q13.1-qter) as a result of paternal inversion (22)(p11q13.1) proved using region-specific FISH probes</article-title>. <source>Chang Gung Med J</source>. <year>2005</year>;<volume>28</volume>:<fpage>657</fpage>–<lpage>661</lpage>.</citation>
</ref>
<ref id="bibr36-0883073811429858">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koolen</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Reardon</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Rosser</surname>
<given-names>EM</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation</article-title>. <source>Eur J Hum Genet</source>. <year>2005</year>;<volume>13</volume>:<fpage>1019</fpage>–<lpage>1024</lpage>.</citation>
</ref>
<ref id="bibr37-0883073811429858">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finsterer</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Central nervous system manifestations of mitochondrial disorders</article-title>. <source>Acta Neurol Scand</source>. <year>2006</year>;<volume>114</volume>:<fpage>217</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr38-0883073811429858">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clay</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Sillivan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Konradi</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia</article-title>. <source>Int J Dev Neurosci</source>. <year>2011</year>;<volume>29</volume>:<fpage>311</fpage>–<lpage>324</lpage>.</citation>
</ref>
<ref id="bibr39-0883073811429858">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacquemont</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Sanlaville</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Redon</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders</article-title>. <source>J Med Genet</source>. <year>2006</year>;<volume>43</volume>:<fpage>843</fpage>–<lpage>849</lpage>.</citation>
</ref>
<ref id="bibr40-0883073811429858">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonaglia</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Giorda</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Beri</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid Syndrome</article-title>. <source>PLoS Genet</source>. <year>2011</year>;<volume>7</volume>: <fpage>e1002173</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>